KPTN and coronary artery disorder: Pathways ranked 1 and 3, ‘regulation of cholesterol esterification’ and ‘LDL particle remodeling’, strongly suggested that KPTN can affect CAD risk via cholesterol metabolism (Supplementary Fig. 12a, b).